Sagespring Wealth Partners’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$507K Buy
963
+47
+5% +$26.4K 0.01% 524
2026
Q1
$515K Sell
916
-93
-9% -$59.6K 0.01% 490
2025
Q4
$683K Buy
1,009
+129
+15% +$87.9K 0.01% 400
2025
Q3
$562K Buy
880
+124
+16% +$75.3K 0.01% 433
2025
Q2
$406K Buy
756
+211
+39% +$101K 0.01% 491
2025
Q1
$229K Buy
+545
New +$237K 0.01% 604

Other funds holding IDXX

Sagespring Wealth Partners's IDXX Position: Q2 2026 in Review

Sagespring Wealth Partners increased its Idexx Laboratories (IDXX) stake by 5.1% in Q2 2026, buying an estimated $26.4K and bringing the position to 963 shares worth $507K. The position accounts for 0.01% of the portfolio, ranked #524.

Sagespring Wealth Partners first reported a position in IDXX in Q1 2025 and has held it in 6 quarters since. The position peaked at $683K in Q4 2025. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Sagespring Wealth Partners held 963 shares of Idexx Laboratories worth $507K as of Q2 2026.
  • Sagespring Wealth Partners bought 47 Idexx Laboratories shares in Q2 2026, an estimated $26.4K.
  • Idexx Laboratories made up 0.01% of Sagespring Wealth Partners's portfolio in Q2 2026, its #524 holding.
  • Sagespring Wealth Partners first reported a position in Idexx Laboratories in Q1 2025 and has held it in 6 quarters since.
  • Sagespring Wealth Partners's Idexx Laboratories position peaked at $683K in Q4 2025.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Sagespring Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.